Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $22.92 in the prior trading day, Nurix Therapeutics Inc (NASDAQ: NRIX) closed at $21.79, down -4.93%. In other words, the price has decreased by -$4.93 from its previous closing price. On the day, 1.93 million shares were traded. NRIX stock price reached its highest trading level at $22.71 during the session, while it also had its lowest trading level at $20.65.
Ratios:
Our goal is to gain a better understanding of NRIX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.28 and its Current Ratio is at 5.28. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, UBS on October 24, 2024, initiated with a Buy rating and assigned the stock a target price of $35.
On October 11, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $41.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 04 ’24 when Ring Christine sold 3,290 shares for $25.00 per share. The transaction valued at 82,250 led to the insider holds 28,084 shares of the business.
CHRISTINE RING bought 3,290 shares of NRIX for $80,506 on Nov 04 ’24. On Nov 01 ’24, another insider, Ring Christine, who serves as the Chief Legal Officer of the company, sold 5,760 shares for $24.28 each. As a result, the insider received 139,867 and left with 28,084 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NRIX now has a Market Capitalization of 1543523072 and an Enterprise Value of 1202658560. For the stock, the TTM Price-to-Sale (P/S) ratio is 23.34 while its Price-to-Book (P/B) ratio in mrq is 3.88. Its current Enterprise Value per Revenue stands at 21.315 whereas that against EBITDA is -6.452.
Stock Price History:
Over the past 52 weeks, NRIX has reached a high of $29.56, while it has fallen to a 52-week low of $5.65. The 50-Day Moving Average of the stock is -11.09%, while the 200-Day Moving Average is calculated to be 16.28%.
Shares Statistics:
The stock has traded on average 769.36K shares per day over the past 3-months and 1305280 shares per day over the last 10 days, according to various share statistics. A total of 70.84M shares are outstanding, with a floating share count of 68.89M. Insiders hold about 2.75% of the company’s shares, while institutions hold 95.12% stake in the company. Shares short for NRIX as of 1730332800 were 9457834 with a Short Ratio of 12.29, compared to 1727654400 on 9077737. Therefore, it implies a Short% of Shares Outstanding of 9457834 and a Short% of Float of 14.330000000000002.
